IGMS

IGM Biosciences
IGMS

Overview Fund Activity
Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

74 hedge funds and large institutions have $245M invested in IGM Biosciences in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 15 closing their positions.

Holders
74
Holders Change
-8
Holders Change %
-9.76%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
28
Reduced
26
Closed
15
Calls
$912K
Puts
$83K
Net Calls
+$829K
Net Calls Change
-$74K

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$5.41M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$11.6M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$1.78M
4
AG
4
Artal Group
Luxembourg
$34.5M
5
RPAM
5
Rhenman & Partners Asset Management
Sweden
$1.62M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$790K
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$9.78M
3
Victory Capital Management
3
Victory Capital Management
Texas
$0
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$29.1M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$3.03M
Name Market Value Shares Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$45.8M 3,334,355 – –
BBA
2
Baker Bros. Advisors
New York
$43.4M 3,156,656 +554 +0%
AG
3
Artal Group
Luxembourg
$34.5M 2,509,972 +59,972 +2%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$29.1M 2,120,875 -85,532 -4%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$11.6M 845,591 +154,633 +22%
BlackRock
6
BlackRock
New York
$10.6M 770,596 -18,639 -2%
Alkeon Capital Management
7
Alkeon Capital Management
New York
$9.78M 711,777 -121,464 -15%
Vanguard Group
8
Vanguard Group
Pennsylvania
$7.97M 580,362 +3,195 +0.6%
UBS AM
9
UBS AM
Illinois
$6.66M 485,027 +328 +0.1%
Goldman Sachs
10
Goldman Sachs
New York
$5.41M 393,514 +194,588 +98%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$4.46M 324,537 -65,349 -17%
State Street
12
State Street
Massachusetts
$3.16M 229,806 +3,651 +2%
Marshall Wace
13
Marshall Wace
United Kingdom
$3.03M 220,319 -67,109 -23%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.72M 198,057 +4,307 +2%
CS
15
Candriam SCA
Luxembourg
$2.38M 187,799 +28,814 +18%
SB
16
Samsara BioCapital
California
$2.13M 154,664 – –
WP
17
Woodline Partners
California
$2.11M 153,825 +3,825 +3%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$1.78M 129,740 +129,740 New
Northern Trust
19
Northern Trust
Illinois
$1.63M 118,800 -1,248 -1%
RPAM
20
Rhenman & Partners Asset Management
Sweden
$1.62M 95,000 +45,000 +90%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$1.31M 94,992 +49,315 +108%
Charles Schwab
22
Charles Schwab
California
$1.29M 93,816 +22,470 +31%
Morgan Stanley
23
Morgan Stanley
New York
$1.12M 81,684 -10,053 -11%
Nuveen Asset Management
24
Nuveen Asset Management
Illinois
$1.12M 81,169 -1,935 -2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$907K 66,036 -1,096 -2%
1
2 3 4